PHI with Renal sclerosis
How does this condition affect your private health insurance?
Renale Sklerose, or renal sclerosis, refers to the hardening and scarring of kidney tissues, specifically the glomeruli and renal arterioles. This irreversible damage primarily results from chronic hypertension, which constricts and thickens the blood vessels supplying the kidneys, reducing blood flow. Other causes include diabetes mellitus and various chronic kidney diseases. The condition progressively impairs kidney function, leading to reduced filtration capacity, protein in the urine, and an accumulation of waste products. Symptoms are often absent in early stages, but as the disease advances, it can manifest as fatigue, swelling, and high blood pressure, eventually leading to chronic kidney disease and potentially end-stage renal disease requiring dialysis or kidney transplantation. Management focuses on controlling blood pressure and underlying conditions to slow progression.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Insidious onset over years; often asymptomatic initially, with symptoms emerging only in advanced stages.
Duration of Illness (Lifetime)
Chronic and progressive; typically a lifelong condition once diagnosed, often leading to end-stage renal disease.
Cost of Treatment (Initial)
Moderate to high (diagnostic tests like urinalysis, blood tests, imaging, potential biopsy, initial medication to manage hypertension or diabetes).
Cost of Treatment (Lifetime)
Very high; involves lifelong medication, frequent monitoring, and potentially expensive treatments like dialysis or kidney transplantation if the disease progresses to ESRD.
Mortality Rate
Variable; increases significantly with progression to end-stage renal disease (ESRD) and associated cardiovascular complications. Without management, it can be high.
Risk of Secondary Damages
High (cardiovascular disease, anemia, electrolyte imbalances, bone disease, peripheral neuropathy, and ultimately end-stage renal disease requiring renal replacement therapy).
Probability of Full Recovery
Very low to none; sclerosis implies irreversible scarring. Management focuses on slowing progression, not reversing the damage.
Underlying Disease Risk
High (primarily chronic hypertension and diabetes mellitus, but also other primary kidney diseases such as glomerulonephritis or autoimmune conditions).